Leptomeningeal carcinomatosis after major remission to taxane-based front-line therapy in patients with advanced breast cancer.
- 1 January 2002
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 56 (3) , 265-273
- https://doi.org/10.1023/a:1015018808804
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Meningeal carcinomatosis in patients with breast carcinoma: Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimenCancer, 1996
- Central nervous system progression of metastatic breast cancer in patients treated with paclitaxelCancer, 1995
- Carcinomatous meningitis in patients with breast cancer. An aggressive disease variantCancer, 1994
- Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.Journal of Clinical Oncology, 1993
- Association of leptomeningeal carcinomatosis in carcinoma of the breast with infiltrating lobular carcinoma. An autopsy study.1991
- Focal Cerebral Infarctions Associated With Perivascular Tumor Infiltrates in Carcinomatous Leptomeningeal MetastasesArchives of Neurology, 1989
- A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.Journal of Clinical Oncology, 1987
- Confidence Intervals for Reporting Results of Clinical TrialsAnnals of Internal Medicine, 1986
- Central nervous system metastasis from breast carcinoma autopsy studyCancer, 1983
- Adriamycin and 1-(2-Chlorethyl)-3-Cyclohexyl-1-Nitrosourea (CCNU) in the treatment of metastatic breast cancerCancer, 1978